Insomnia costing $42B a year; Minorities, poor less likely to see doctors with EMRs;

> A new report from Sanofi-Aventis and The Center for Medicine in the Public Interest contends that delays in insomnia diagnosis and treatment is costing the U.S. at least $42 billion in direct and indirect healthcare costs per year. Article

> Minorities and the poor are less likely to see doctors who have an electronic medical records system in place, a new study suggests. FierceEMR

> Forest Laboratories had hoped that Celexa would prove to be helpful in cutting down on autistic kids' repetitive behaviors, but sadly for them, a new trial at NIH suggests that it does not. FiercePharma

> Given its prevalence, you won't be surprised to hear that the iPhone is becoming a major battleground for pharmaceutical companies, who see it as a major platform for direct-to-consumer marketing. FierceMobileHealthcare

And Finally... When it came to the battle of the eating titans, Japan captured the flag. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.